One Wealth Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,404
Closed -$124K 304
2025
Q1
$124K Sell
10,404
-3,575
-26% -$48.8K 0.02% 279
2024
Q4
$205K Sell
13,979
-10,366
-43% -$145K 0.03% 239
2024
Q3
$306K Sell
24,345
-581
-2% -$6.33K 0.05% 198
2024
Q2
$252K Sell
24,926
-444
-2% -$3.95K 0.05% 184
2024
Q1
$267K Buy
25,370
+13,249
+109% +$147K 0.05% 197
2023
Q4
$126K Hold
12,121
0.02% 205
2023
Q3
$76.8K Buy
+12,121
New +$89.5K 0.02% 186

Other funds holding ZYME

One Wealth Advisors's ZYME Position: Q2 2025 in Review

One Wealth Advisors sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 10,404 shares — an estimated $124K sold.

One Wealth Advisors first reported a position in ZYME in Q3 2023 and held it in 7 quarters. The position peaked at $306K in Q3 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • One Wealth Advisors reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • One Wealth Advisors sold 10,404 Zymeworks shares in Q2 2025, an estimated $124K.
  • One Wealth Advisors first reported a position in Zymeworks in Q3 2023 and held it in 7 quarters.
  • One Wealth Advisors's Zymeworks position peaked at $306K in Q3 2024.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on One Wealth Advisors's 13F filing for Q2 2025, filed 17 Jul 2025.